---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-028425"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2026-04-29T23:59:59+00:00"
generated_at: "2026-05-15T02:22:55.107425+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# TriSalus Life Sciences Chief of Clinical Operations Jodi Devlin to retire October 1, 2026

## Summary
- Jodi Devlin notified Company on April 24, 2026 of retirement as Chief of Clinical Operations.
- Retirement effective October 1, 2026; Company expresses gratitude for her contributions.
- Previously announced Dr. Richard Marshall as new Chief Medical Officer effective June 29, 2026.

## SEC filing metadata
- accession: 0001628280-26-028425
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2026-04-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000162828026028425/0001628280-26-028425-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000162828026028425/tlsi-20260424.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-028425
- JSON: https://secwatch.observer/filing/0001628280-26-028425.json
- Plain text: https://secwatch.observer/filing/0001628280-26-028425.txt

## Key facts
- Executive change
  Jodi Devlin departed as Chief of Clinical Operations at TriSalus Life Sciences, Inc..
  - Action: retire
  - Role: Chief of Clinical Operations
  source text: On April 24, 2026, Jodi Devlin provided notice to TriSalus Life Sciences, Inc. (the “Company”) of her intention to retire from her role as Chief of Clinical Operations, effective October 1, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000162828026028425/0001628280-26-028425-index.htm
- Executive change
  Dr. Richard Marshall was appointed as Chief Medical Officer at TriSalus Life Sciences, Inc..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: As previously announced on April 7, 2026, the Company appointed Dr. Richard Marshall to Chief Medical Officer of the Company, effective June 29, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000162828026028425/0001628280-26-028425-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.